This topic contains a solution. Click here to go to the answer

Author Question: When should intravenous access and medication be considered during pulseless ventricular ... (Read 14 times)

kwoodring

  • Hero Member
  • *****
  • Posts: 560
When should intravenous access and medication be considered during pulseless ventricular tachycardia?
 
  a. After beginning cardiopulmonary resuscitation (CPR) and attempting defibrillation
  b. Before beginning CPR and attempting defibrillation
  c. When the patient has an established advanced airway
  d. Intravenous access and medication are not a part of the treatment algorithm for pulseless ventricular tachycardia

Question 2

Ablation with radiofrequency current is effective in the treatment of
 
  a. atrial fibrillation (AF) caused by multiple circuits.
  b. asystole.
  c. sinus rhythm.
  d. AF caused by single primary circuit.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Koolkid240

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

ANS: A

Answer to Question 2

ANS: D




kwoodring

  • Member
  • Posts: 560
Reply 2 on: Jul 16, 2018
Gracias!


mcarey591

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

For a complete list of videos, visit our video library